Condition: Obesity · Overweight · Sponsor: Eli Lilly and Company
This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additional evidence for the potential clinical benefits of tirzepatide in this population.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC | Gilbert, Arizona, United States | — |
| Aventiv Research | Mesa, Arizona, United States | — |
| Elite Clinical Studies | Phoenix, Arizona, United States | — |
| Pima Heart | Tucson, Arizona, United States | — |
| KLR Business Group, Inc. dba Arkansas Clinical Research | Little Rock, Arkansas, United States | — |
| Smart Cures Clinical Research | Anaheim, California, United States | — |
| Kidney & Hypertension Center - Apple Valley | Apple Valley, California, United States | — |
| Hope Clinical Research, Inc. | Canoga Park, California, United States | — |
| John Muir Physician Network Research Center | Concord, California, United States | — |
| Neighborhood Healthcare Institute of Health | Escondido, California, United States | — |
| HB Clinical Trials - Fountain Valley | Fountain Valley, California, United States | — |
| Valiance Clinical Research | Huntington Park, California, United States | — |
+ 659 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.